All Articles

Shake Shack's lowered guidance reveals a consumer trading down from premium burgers, a worrying sign for the entire fast-casual industry's health.

Ahead of its token launch, nGRND has drawn 855k gamers with a novel promise: rewards backed by preserved, unmined gold. Is this the future of Web3?

Darigold's partnership with Actus Nutrition isn't a retreat, but a strategic masterstroke redefining the value of milk in a high-tech protein market.

Zacks Investment Management launches two new income ETFs, ZINC and PRIZ, targeting an 8% yield. But can their 'simple', research-driven approach deliver?

With a $1.25 billion investment from Apollo Funds, McKesson is spinning off its medical supply unit. Is this a cure for corporate bloat or a new symptom of financialization in healthcare?

Frazier Healthcare Partners adds Milton Boyer as an EIR, signaling a strategic push into the complex pharmaceutical manufacturing sector with a proven operator.

As AI-powered cyberattacks escalate, one company is fighting fire with fire. Skyhawk Security's award-winning AI Red Team is a game-changer.

AI is moving from the cloud to the world around us. New, powerful hardware is making our cities and industries smarter, but it demands a new level of trust.

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

As Motorcar Parts of America preps its FY2026 report, investors await answers on declining revenue and the strategic review of its once-touted EV business.

Inipharm's INI-822 study leverages genetic insights for an oral MASH therapy, challenging injectable rivals and offering new hope for high-risk patients.

A Canadian firm is betting big on natural hydrogen, a clean energy source found underground. With new funding and political clout, is this the future?

As a key architect of its global manufacturing retires, Alliance Laundry bets on financial discipline and investor savvy to drive its next growth cycle.

Medscape's new AI symposium aims to guide hematologists through an ethical revolution, promising to enhance, not replace, clinical expertise. Is this the future?

As AI and cyber risks escalate, the new 'Chief Trust Officer' role is emerging. HITRUST's appointment of a veteran leader signals a major shift for all.

Despite massive security investments, known vulnerabilities are wreaking havoc. A new report reveals why AI demands a shift from pre-production to runtime defense.

JFrog's inclusion in the Russell 3000 isn't just a corporate win; it's a signal of the market's new respect for the software supply chain's vital role.

With real estate worth more than its stock and ambitious R&D plans, Cosmos Health claims it's undervalued. But is an unusual crypto strategy clouding the picture?

An analysis of 89 school districts reveals a new data-driven playbook for reducing chronic absenteeism, with major implications for EdTech and human capital.

The 'better-for-you' brand is betting on a booming peanut butter market with its first non-chocolate snack, a strategic move backed by deep market data.